Healthcare · NSE: GLENMARK
Glenmark Pharmaceuticals Limited
₹2,300.00
+1.51% · close 28 Oct 2026
52-week range
₹1,810.40 – ₹2,515.00
From 52W high
-8.55%
Return 1Y
+26.71%
Volume · Avg 20D
4.56 L · 6.43 L
Returns & technicals
1W+4.83%
1M-3.36%
3M+5.28%
6M-1.08%
1Y+26.71%
| 50-day average | ₹2,354.36 below |
| 200-day average | ₹2,220.96 above |
| Volatility (1Y, annualised) | 27.90% |
| RSI (14) | 51.7 |
| MACD histogram (12, 26, 9) | 6.15 |
| Delivery · 20D avg | 40.19% · 51.35% |
| Turnover (last day) | ₹105 Cr |
Profile
| Symbol | GLENMARK |
| ISIN | INE935A01035 |
| Sector | Healthcare |
| Listed on NSE | 7 Feb 2000 |
| Face value | ₹1 |
| Series | EQ |
Financials & shareholding
Quarterly results and the shareholding pattern for GLENMARK aren't available right now.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |